Slilaty Steve N. 4
4 · Sunshine Biopharma, Inc · Filed Sep 23, 2019
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Award
Common Stock
2019-09-02$0.00/sh+13,000,000$13,000→ 18,869,219 total
Footnotes (1)
- [F1]Effective February 1, 2019, the Issuer effectuated a reverse stock split wherein 1 share of Common Stock was issued for each 20 shares of the issued and outstanding Common Stock of the Issuer resulting in Reporting Person owning 5,869,219 shares of Common Stock of the Issuer as of that date.